List of Revised CPT codes of 2018 for Medical coders

Evaluation and Management

 99217             Observation care discharge day management (This code is to be utilized to report all services provided to a patient on discharge from outpatient hospital “observation status” if the discharge is on other than the initial date of “observation status.” To report services to a patient designated as “observation status” or “inpatient status” and discharged on the same date, use the codes for Observation or Inpatient Care Services [including Admission and Discharge Services, 99234-99236 as appropriate.])

 99218           Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components:

A detailed or comprehensive history;

A detailed or comprehensive examination; and

Medical decision making that is straightforward or of low complexity.

Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient’s and/or family’s needs.

Usually, the problem(s) requiring admission to outpatient hospital “observation status” are of low severity. Typically, 30 minutes are spent at the bedside and on the patient’s hospital floor or unit.

 99219          Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components:

A comprehensive history;

A comprehensive examination; and

Medical decision making of moderate complexity.

Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient’s and/or family’s needs.

Usually, the problem(s) requiring admission to outpatient hospital “observation status” are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient’s hospital floor or unit.

99220            Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components:

A comprehensive history;

A comprehensive examination; and

Medical decision making of high complexity.

Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient’s and/or family’s needs.

Usually, the problem(s) requiring admission to outpatient hospital “observation status” are of high severity. Typically, 70 minutes are spent at the bedside and on the patient’s hospital floor or unit.

17250        Chemical cauterization of granulation tissue (ie, proud flesh) sinus or fistula)

 31254        Nasal/sinus endoscopy, surgical; with ethmoidectomy, with ethmoidectomy;partial (anterior)

31255           with ethmoidectomy;total (anterior and posterior)

 31276           Nasal/sinus endoscopy, surgical with frontal sinus exploration, with or without including removal of tissue from frontal sinus,when performed

31645           with therapeutic aspiration of tracheobronchial tree, initial (eg, drainage of lung abscess)

31646          with therapeutic aspiration of tracheobronchial tree, subsequent, same hospital stay

32998         Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, radiofrequency including imaging guidance when performed, unilateral; radiofrequency

34812          Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)

34820         Open iliac artery exposure for delivery of endovascular prosthesis or iliac occlusion during endovascular therapy, by abdominal or retroperitoneal incision, unilateral (List separately in addition to code for primary procedure)

 34833        Open iliac artery exposure with creation of conduit for delivery of aortic or iliac endovascular prosthesis or for establishment of cardiopulmonary bypass, by abdominal or retroperitoneal incision, unilateral (List separately in addition to code for primary procedure)

 34834        Open brachial artery exposure to assist in the deployment of aortic or iliac endovascular prosthesis by arm incision, unilateraly for delivery of endovascular prosthesis, unilateral (List separately in addition to code for primary procedure)

36140          Introduction of needle or intracatheter, upper or lower extremity artery extremity artery

36468         Single or multiple injections Injection(s) of sclerosing solutions;sclerosant for spider veins (telangiectasia), limb or trunk

36470          Injection of sclerosin solution sclerosant; single incompetent vein (other than telangiectasia)

 36471         multiple incompetent veins (other than telangiectasia), same leg

36516          with extracorporeal immunoadsorption, selective adsorption or selective filtration and plasma reinfusion

36908        Transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the stenting, and all angioplasty in the central dialysis segment (List separately in addition to code for primary procedure)

38220        Bone Diagnostic bone marrow; aspiration only(s)

38221         biopsy; needle or tracar(ies)

43112         Total or near total esophagectomy, with thoracotomy; with pharyngogastrostomy or cervical esophagogastrostomy, with or without pyloroplasty (ie, McKeown esophagectomy or tri-incisional esophagectomy)

57240         Anterior colporrhaphy, repair of cystocele with or without repair of urethrocele, including cystourethroscopy, when performed

57260           Combined anteroposterior colporrhaphy, including cystourethroscopy, when performed;

57265           with enterocele repair

64550         Application of surface (transcutaneous) neurostimulator (eg, TENS unit)

76000         Fluoroscopy (separate procedure), up to 1 hour physician or other qualified health care professional time other than 71023 or 71034 (eg, cardiac fluoroscopy)

76881          Ultrasound, extremity, nonvascular; complete joint (ie, joint space and peri-articular soft tissue structures) real-time with image documentation: complete

76882         Ultrasound, limited, anatomic specific joint or other nonvascular extremity structure(s) (eg, joint space, peri-articular tendon[s], muscle[s], nerve[s], other soft tissue structure[s], or soft tissue mass[es]), real-time with image documentation

 80305        Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service

80306          read by instrument assisted direct optical observation (eg, dipsticks utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service

80307          by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service

81257          HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis;, for common deletions or variant (eg, Southeast Asian, Thai, Filipino, Mediterranean, alpha3.7, alpha4.2, alpha20.5, Constant Spring)

81400          Molecular pathology procedure, Level 1 (eg, identification of single germline variant [eg, SNP] by techniques such as restriction enzyme digestion or melt curve analysis)

DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism), IVS14+1GA variant

Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-1a/b (L33P)

Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-2a/b (T145M)

Read also  2023 August CPT Assistant Question and Answers

FREE CPT Code Search Tool (Click Here)

MUST BUY CPT & ICD-10 CM  CODING EBOOKS 

Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-3a/b (I843S)

Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-4a/b (R143Q)

Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-5a/b (K505E)

Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-6a/b (R489Q)

Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-9a/b (V837M)

Human Platelet Antigen 15 genotyping (HPA-15), CD109 (CD109 molecule) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-15a/b (S682Y)

IL28B (interleukin 28B [interferon, lambda 3]) (eg, drug response), rs12979860 variant

SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), V174A variant

81401        Molecular pathology procedure, Level 2 (eg, 2-10 SNPs, 1 methylated variant, or 1 somatic variant [typically using nonsequencing target variant analysis], or detection of a dynamic mutation disorder/triplet repeat)

CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) (eg, drug metabolism), common variants (eg, *2, *3, *4, *5, *6)

CYP3A5 (cytochrome P450, family 3, subfamily A, polypeptide 5) (eg, drug metabolism), common variants (eg, *2, *3, *4, *5, *6)

HBB (hemoglobin, beta) (eg, sickle cell anemia, hemoglobin C, hemoglobin E), common variants (eg, HbS, HbC, HbE)

LINC00518 (long intergenic non-protein coding RNA 518) (eg, melanoma), expression analysis

PRAME (preferentially expressed antigen in melanoma) (eg, melanoma), expression analysis

TPMT (thiopurine S-methyltransferase) (eg, drug metabolism), common variants (eg, *2, *3)

TYMS (thymidylate synthetase) (eg, 5-fluorouracil/5-FU drug metabolism), tandem repeat variant

81403                   Molecular pathology procedure, Level 4 (eg, analysis of single exon by DNA sequence analysis, analysis of 10 amplicons using multiplex PCR in 2 or more independent reactions, mutation scanning or duplication/deletion variants of 2-5 exons)

HBB (hemoglobin, beta, beta-globin) (eg, beta thalassemia), duplication/deletion analysis

IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common exon 4 variants (eg, R132H, R132C)

IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common exon 4 variants (eg, R140W, R172M)

 81404            Molecular pathology procedure, Level 5 (eg, analysis of 2-5 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 6-10 exons, or characterization of a dynamic mutation disorder/triplet repeat by Southern blot analysis)

HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia), duplication/deletion analysis

HBB (hemoglobin, beta, Beta-Globin) (eg, thalassemia), full gene sequence

  81405              Molecular pathology procedure, Level 6 (eg, analysis of 6-10 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 11-25 exons, regionally targeted cytogenomic array analysis)

CPOX (coproporphyrinogen oxidase) (eg, hereditary coproporphyria), full gene sequence

CTRC (chymotrypsin C) (eg, hereditary pancreatitis), full gene sequence

F9 (coagulation factor IX) (eg, hemophilia B), full gene sequence

HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, thalassemia), full gene sequence

PKLR (pyruvate kinase, liver and RBC) (eg, pyruvate kinase deficiency), full gene sequence

 81406            Molecular pathology procedure, Level 7 (eg, analysis of 11-25 exons by DNA sequence analysis, mutation scanning or duplication/deletion variants of 26-50 exons, cytogenomic array analysis for neoplasia)

ANOS1 (anosmin-1) (eg, Kallmann syndrome 1), full gene sequence

HMBS (hydroxymethylbilane synthase) (eg, acute intermittent porphyria), full gene sequence

KAL1 (Kallmann syndrome 1 sequence) (eg, Kallmann syndrome), full gene sequence

PPOX(protoporphyrinogen oxidase) (eg, variegate porphyria), full gene sequence